Tredje AP fonden Has $1.28 Million Holdings in Corteva (NYSE:CTVA)
Tredje AP fonden grew its position in Corteva (NYSE:CTVA) by 19.7% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 54,616 shares of the company’s stock after buying an additional 8,995 shares during the period. Tredje AP fonden’s holdings in Corteva were worth $1,283,000 at the end of the most recent reporting period.
Several other institutional investors also recently made changes to their positions in the stock. Panagora Asset Management Inc. raised its holdings in shares of Corteva by 1.3% in the 4th quarter. Panagora Asset Management Inc. now owns 29,485 shares of the company’s stock worth $872,000 after purchasing an additional 384 shares during the period. Versant Capital Management Inc boosted its stake in Corteva by 21.8% during the first quarter. Versant Capital Management Inc now owns 2,239 shares of the company’s stock valued at $52,000 after buying an additional 401 shares in the last quarter. Center for Financial Planning Inc. lifted its holdings in shares of Corteva by 63.5% during the first quarter. Center for Financial Planning Inc. now owns 1,102 shares of the company’s stock valued at $26,000 after purchasing an additional 428 shares during the last quarter. Rockefeller Capital Management L.P. lifted its holdings in shares of Corteva by 1.8% during the first quarter. Rockefeller Capital Management L.P. now owns 24,469 shares of the company’s stock valued at $575,000 after purchasing an additional 431 shares during the last quarter. Finally, Ameritas Investment Company LLC lifted its stake in Corteva by 15.1% in the 4th quarter. Ameritas Investment Company LLC now owns 3,322 shares of the company’s stock worth $98,000 after acquiring an additional 435 shares in the last quarter. 78.04% of the stock is owned by institutional investors and hedge funds.
CTVA has been the topic of a number of analyst reports. Royal Bank of Canada increased their price objective on Corteva from $27.00 to $31.00 and gave the company an “outperform” rating in a report on Monday, May 11th. Credit Suisse Group cut their target price on Corteva from $31.00 to $28.00 and set a “neutral” rating for the company in a research report on Tuesday, May 5th. Zacks Investment Research raised Corteva from a “sell” rating to a “hold” rating in a research note on Monday, May 18th. Deutsche Bank decreased their price objective on Corteva from $34.00 to $32.00 and set a “buy” rating for the company in a research note on Friday, May 8th. Finally, Cleveland Research assumed coverage on Corteva in a research note on Friday. They set a “neutral” rating for the company. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and eleven have issued a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $30.69.
Corteva (NYSE:CTVA) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.20. Corteva had a positive return on equity of 5.09% and a negative net margin of 5.91%. The business had revenue of $3.96 billion during the quarter, compared to the consensus estimate of $3.56 billion. The business’s revenue for the quarter was up 16.5% compared to the same quarter last year. On average, research analysts anticipate that Corteva will post 1.36 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Friday, May 15th were given a $0.13 dividend. This represents a $0.52 dividend on an annualized basis and a dividend yield of 2.00%. The ex-dividend date was Thursday, May 14th. Corteva’s payout ratio is 36.36%.
Corteva, Inc provides agriculture products worldwide. The company develops and supplies germplasm and traits in corn, soybean, and sunflower seed markets. It also supplies products to the agricultural input industry that protect against weeds, insects and other pests, and diseases, as well as to enhance crop health.
Further Reading: Call Option Volume
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.